Sergio Vioglio

Title: The Innovative Contributions of Sergio Vioglio

Introduction

Sergio Vioglio is a notable inventor based in Cusano Milanino, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 10 patents to his name, Vioglio's work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

One of Vioglio's latest patents includes the development of 1H-thieno[2,3-c]pyrazole derivatives, which are useful as kinase inhibitors. These compounds, defined by a specific formula and their pharmaceutically acceptable salts, are disclosed in the patent specification. The invention outlines a process for their preparation and pharmaceutical compositions that comprise these compounds. The therapeutic potential of these derivatives lies in their ability to treat diseases associated with disregulated protein kinase activity, such as cancer.

Career Highlights

Throughout his career, Sergio Vioglio has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Pharmacia & Upjohn S.p.a. and Farmitalia Carlo Erba S.p.a. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Vioglio has collaborated with several professionals in his field, including Carlo Battistini and Giovanni Franceschi. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Sergio Vioglio's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on kinase inhibitors demonstrates the potential for advancements in cancer treatment and showcases the importance of continued research and collaboration in the scientific community.